Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00368056
Status:
COMPLETED
Last Update Posted:
2012-02-22
First Post:
2006-08-23
Brief Title:
Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability
Sponsor:
Sumitomo Pharma America Inc
Organization:
Sumitomo Pharma America Inc
Organization Data
Organization:
Sumitomo Pharma America Inc
Class:
INDUSTRY
Study ID:
190-060
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sumitomo Pharma America Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None